1. Short title This Act may be cited as the Label and Transport Tissues Safely Act of 2017 or as the LATTS Act of 2017 . 2. In general (a) Non-Transplant Tissue Bank license (1) Prohibition No person may introduce or deliver for introduction into interstate commerce any human tissue specimen for medical research or education unless— (A) a non-transplant tissue bank license is in effect for the entity introducing the human tissue specimen into interstate commerce; (B) each package of the human tissue specimen is labeled with— (i) the proper name of the human tissue specimen contained in the package; (ii) the name, address, and applicable license number of the source tissue bank of the human tissue specimen; (iii) a unique donor identifier, the tissue type, the cause of death, serological test results, and any known infectious disease agents; (iv) a statement about the mandatory use of personal protective equipment and universal precautions when handling human tissue; and (v) the statement not for transplantation ; and (C) each package of the human tissue specimen is wrapped and packaged in a manner that— (i) mitigates potential contamination and cross contamination; (ii) mitigates potential safety hazards; (iii) is sealed to prevent leakage; and (iv) ensures the integrity of the tissue. (2) Procedures established (A) In general The Secretary of Health and Human Services shall establish, by rule, requirements for the approval, suspension, and revocation of non-transplant tissue bank licenses. (B) Approval The Secretary shall approve a non-transplant tissue bank license application— (i) on the basis of a demonstration that— (I) the human tissue specimens of the applicant are legally donated, properly screened for communicable disease agents, properly labeled, transported, and stored, and used according to the donor’s donation authorization